Oncimmune Holdings plc (AIM: ONC)

Market Cap	16.88M
Revenue (ttm)	1.21M
Net Income (ttm)	7.12M
Shares Out	111.77M
EPS (ttm)	0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	39,841
Open	14.90
Previous Close	14.85
Day's Range	14.90 - 15.40
52-Week Range	9.35 - 31.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 20, 2024

About Oncimmune Holdings

Oncimmune Holdings plc, a precision medicine company, provides autoantibody biomarker profiling in immuno-oncology, autoimmune, and infectious diseases in Europe and internationally. It offers ImmunoINSIGHTS, an autoantibody profiling service that unlocks the immune system to discover and convert autoantibodies into actionable biomarkers; Sero Tag, a discovery engine which identifies relevant biomarker pool for target discovery or companion diagnostics; NavigAID, a creation of a disease-specific biomarker panel; and Autoantibody Biomarkers, a c...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2015
• Employees: 38
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: ONC